Professor Sarah Gilbert

article

Vaccine innovation in the UK: SMEs and national capabilities

The UK Government is supporting the development of COVID-19 vaccines,…

14 December 2020 | By Dr Gabriela Juárez Martínez (KTN), Dr Marcel Kuiper (KTN)

The UK Government is supporting the development of COVID-19 vaccines, including two innovative UK vaccine candidates. In this article, we describe the history of these candidates and introduce innovative small and medium enterprises (SMEs) and national capabilities that are working to combat the current pandemic and improve the UK’s vaccine…

news

UK’s SARS-CoV-2 vaccine candidate is safe and induces antibody and T cell response

Data released from the Phase I/II trial of the ChAdOx1…

21 July 2020 | By Hannah Balfour (European Pharmaceutical Review)

Data released from the Phase I/II trial of the ChAdOx1 COVID-19 vaccine candidate suggests it elicits an immune response with no adverse effects.

news

CDMO delivers 4,000 doses of COVID-19 vaccine candidate for Phase II/III trial

Advent announced it has manufactured and delivered the first 4,000…

29 May 2020 | By Hannah Balfour (European Pharmaceutical Review)

Advent announced it has manufactured and delivered the first 4,000 doses of the AZD1222 vaccine candidate for the University of Oxford clinical trial.